Dr. Vassilis E. Koliatsos is the senior neuropsychiatrist for Research and Education and the Stulman Scholar in Clinical Neurospychiatry at Sheppard Pratt.
Dr. Koliatsos, who is also professor in Psychiatry, Neurology, and Neuropathology at the Johns Hopkins University School of Medicine and Clinical Professor of Psychiatry at the University of Maryland School of Medicine, founded the Neuropsychiatry Program at Sheppard Pratt in 1997 to establish a coordinated approach to care for a variety of complex patients with severe cognitive, emotional, and behavioral problems across life cycle, from development to advanced age. With generous funding from the Stulman foundation, the Women’s Hospital Foundation, and other grateful patient families, the Neuropsychiatry Program was designed to help clarify the causes and mechanisms of symptoms and provides both consultative services and direct patient care. Dr. Koliatsos sees patients in the general neuropsychiatry teaching clinic focusing on general neuropsychiatry, TBI, neurodegenerative dementias, and complex psychopharmacological cases.
His active teaching curriculum includes bedside teaching for first-year and rotating senior residents and classroom teaching for second-year residents. He has also been running the biweekly Neuropsychiatry rounds for twenty years.
Dr. Koliatsos’ main clinical and research interests focus on how the nervous system deals with traumatic ‘insults’ and what it does to repair itself; or in the case of failure or clinical disease, what can be done therapeutically to help simple and complex functioning, reset neurotransmitter systems, or even repair circuits with novel methodologies.
Dr. Koliatsos graduated summa cum laude from the University of Athens School of Medicine, and completed additional clinical training in internal medicine and neurology while in the Greek Navy. Dr. Koliatsos then received a NATO fellowship and subsequently entered the Department of Neurology at Johns Hopkins University to begin postdoctoral studies on mechanisms of neurodegenerative diseases. While training there, he established his own laboratory within the Division of Neuropathology and Hopkins’ Alzheimer’s Disease Research Center, and simultaneously completed clinical training in psychiatry at Sheppard Pratt.